518 related articles for article (PubMed ID: 21148102)
1. Rad52 inactivation is synthetically lethal with BRCA2 deficiency.
Feng Z; Scott SP; Bussen W; Sharma GG; Guo G; Pandita TK; Powell SN
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):686-91. PubMed ID: 21148102
[TBL] [Abstract][Full Text] [Related]
2. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
Lok BH; Carley AC; Tchang B; Powell SN
Oncogene; 2013 Jul; 32(30):3552-8. PubMed ID: 22964643
[TBL] [Abstract][Full Text] [Related]
3. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
Cramer-Morales K; Nieborowska-Skorska M; Scheibner K; Padget M; Irvine DA; Sliwinski T; Haas K; Lee J; Geng H; Roy D; Slupianek A; Rassool FV; Wasik MA; Childers W; Copland M; Müschen M; Civin CI; Skorski T
Blood; 2013 Aug; 122(7):1293-304. PubMed ID: 23836560
[TBL] [Abstract][Full Text] [Related]
4. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
[TBL] [Abstract][Full Text] [Related]
5. Recovery of deficient homologous recombination in Brca2-depleted mouse cells by wild-type Rad51 expression.
Lee SA; Roques C; Magwood AC; Masson JY; Baker MD
DNA Repair (Amst); 2009 Feb; 8(2):170-81. PubMed ID: 18992372
[TBL] [Abstract][Full Text] [Related]
6. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway.
Chun J; Buechelmaier ES; Powell SN
Mol Cell Biol; 2013 Jan; 33(2):387-95. PubMed ID: 23149936
[TBL] [Abstract][Full Text] [Related]
7. Expression of human BRCA2 in Saccharomyces cerevisiae complements the loss of RAD52 in double-strand break repair.
Law S; Park H; Shany E; Sandhu S; Vallabhaneni M; Meyer D
Curr Genet; 2023 Dec; 69(4-6):301-308. PubMed ID: 37934232
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal dynamics of homologous recombination repair at single collapsed replication forks.
Whelan DR; Lee WTC; Yin Y; Ofri DM; Bermudez-Hernandez K; Keegan S; Fenyo D; Rothenberg E
Nat Commun; 2018 Sep; 9(1):3882. PubMed ID: 30250272
[TBL] [Abstract][Full Text] [Related]
9. Effect of the expression of BRCA2 on spontaneous homologous recombination and DNA damage-induced nuclear foci in Saccharomyces cerevisiae.
Spugnesi L; Balia C; Collavoli A; Falaschi E; Quercioli V; Caligo MA; Galli A
Mutagenesis; 2013 Mar; 28(2):187-95. PubMed ID: 23328489
[TBL] [Abstract][Full Text] [Related]
10. Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
Al-Mugotir M; Lovelace JJ; George J; Bessho M; Pal D; Struble L; Kolar C; Rana S; Natarajan A; Bessho T; Borgstahl GEO
PLoS One; 2021; 16(3):e0248941. PubMed ID: 33784323
[TBL] [Abstract][Full Text] [Related]
11. Ionizing radiation-induced foci formation of mammalian Rad51 and Rad54 depends on the Rad51 paralogs, but not on Rad52.
van Veelen LR; Essers J; van de Rakt MW; Odijk H; Pastink A; Zdzienicka MZ; Paulusma CC; Kanaar R
Mutat Res; 2005 Jul; 574(1-2):34-49. PubMed ID: 15914205
[TBL] [Abstract][Full Text] [Related]
12. Homologous recombination in budding yeast expressing the human RAD52 gene reveals a Rad51-independent mechanism of conservative double-strand break repair.
Manthey GM; Clear AD; Liddell LC; Negritto MC; Bailis AM
Nucleic Acids Res; 2017 Feb; 45(4):1879-1888. PubMed ID: 27923995
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement.
Lok BH; Powell SN
Clin Cancer Res; 2012 Dec; 18(23):6400-6. PubMed ID: 23071261
[TBL] [Abstract][Full Text] [Related]
14. Distinct RAD51 associations with RAD52 and BCCIP in response to DNA damage and replication stress.
Wray J; Liu J; Nickoloff JA; Shen Z
Cancer Res; 2008 Apr; 68(8):2699-707. PubMed ID: 18413737
[TBL] [Abstract][Full Text] [Related]
15. Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells.
Tseng WC; Chen CY; Chern CY; Wang CA; Lee WC; Chi YC; Cheng SF; Kuo YT; Chiu YC; Tseng ST; Lin PY; Liou SJ; Li YC; Chen CC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922657
[TBL] [Abstract][Full Text] [Related]
16. The function of RAD52 N-terminal domain is essential for viability of BRCA-deficient cells.
Hanamshet K; Mazin AV
Nucleic Acids Res; 2020 Dec; 48(22):12778-12791. PubMed ID: 33275133
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
18. Non-Recombinogenic Functions of Rad51, BRCA2, and Rad52 in DNA Damage Tolerance.
Prado F
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680945
[TBL] [Abstract][Full Text] [Related]
19. Replication fork reversal triggers fork degradation in BRCA2-defective cells.
Mijic S; Zellweger R; Chappidi N; Berti M; Jacobs K; Mutreja K; Ursich S; Ray Chaudhuri A; Nussenzweig A; Janscak P; Lopes M
Nat Commun; 2017 Oct; 8(1):859. PubMed ID: 29038466
[TBL] [Abstract][Full Text] [Related]
20. POLθ-mediated end joining is restricted by RAD52 and BRCA2 until the onset of mitosis.
Llorens-Agost M; Ensminger M; Le HP; Gawai A; Liu J; Cruz-García A; Bhetawal S; Wood RD; Heyer WD; Löbrich M
Nat Cell Biol; 2021 Oct; 23(10):1095-1104. PubMed ID: 34616022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
